❭ Publications ❭ Supplementary data ❭

Supplementary data

Kresse SH, Meza-Zepeda LA, Machado I, Llombart-Bosch A, Myklebost O (2011) Cancer In press Genomic validation of preclinical xenograft models of human sarcoma reveals recurrent loss of aberrations

Supplementary Figure 1

Supplementary Table 1

Supplementary Table 2

Supplementary Table 3

Supplementary Table 4

More
Scroll to top

Home Myklebost

  • Group members
  • Myklebost's web page @UiB
  • News
  • Research interests
  • Former Projects
  • Pasientinformasjon
  • Publications
    • 2016
    • 2015
    • 2014
    • 2013
    • 2012
    • 2011
    • 2010
    • 2009
    • 2008
    • 2007
    • 2006
    • 2005
    • 2004
    • 2003
    • 2002
    • 2001
    • Previous years
    • Supplementary data
    • Internal data base
  • Internal group info
  • Available positions
  • How to get here
    • Map of communications
    • Shuttle bus Montebello-Gaustad

Recent publications

Namløs HM, Khelik K, Nakken S, Vodák D, Hovig E, Myklebost O, Boye K, Meza-Zepeda LA (2023)
Chromosomal instability and a deregulated cell cycle are intrinsic features of high-risk gastrointestinal stromal tumours with a metastatic potential
Mol Oncol (in press)
DOI 10.1002/1878-0261.13514, PubMed 37622176

Ballinger ML, Pattnaik S, Mundra PA, Zaheed M, Rath E, Priestley P, Baber J, Ray-Coquard I, Isambert N, Causeret S, van der Graaf WTA, Puri A, Duffaud F, Le Cesne A, Seddon B, Chandrasekar C, Schiffman JD, Brohl AS, James PA, Kurtz JE, Penel N, Myklebost O, Meza-Zepeda LA, Pickett H, Kansara M et al. (2023)
Heritable defects in telomere and mitotic function selectively predispose to sarcomas
Science, 379 (6629), 253-260
DOI 10.1126/science.abj4784, PubMed 36656928

Venizelos A, Engebrethsen C, Deng W, Geisler J, Geisler S, Iversen GT, Aas T, Aase HS, Seyedzadeh M, Steinskog ES, Myklebost O, Nakken S, Vodak D, Hovig E, Meza-Zepeda LA, Lønning PE, Knappskog S, Eikesdal HP (2022)
Clonal evolution in primary breast cancers under sequential epirubicin and docetaxel monotherapy
Genome Med, 14 (1), 86
DOI 10.1186/s13073-022-01090-2, PubMed 35948919



More publications


Group contact info:
Myklebost +47 22 93 42 99
Switchb.+47 22 93 40 00
Fax +47 22 52 24 21
olam@radium.uio.no

Local map

Professor at
Dept. of Molecular Biosciences
University of Oslo



We are grateful to be supported by the
Norwegian Cancer Society